Volume 24, Number 4—April 2018
Research
Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010–2016
Table 1
1 | 2 | 3 | 4 | Total | PHE | PHS | A | B | C | E | NG | W | W/Y | X | Y | Z | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2010−11 | 464 | 37 | 36 | 13 | 550 | 1,009 (46.0) | 76 (47.4) | 1 | 423 | 13 | 1 | 5 | 27 | 2 | 1 | 76 | 1 | ||
2011−12 | 370 | 28 | 30 | 11 | 439 | 730 (50.7) | 56 (53.6) | 0 | 311 | 18 | 1 | 4 | 32 | 1 | 0 | 72 | 0 | ||
2012−13 | 415 | 29 | 34 | 13 | 491 | 769 (54.0) | 66 (51.5) | 0 | 325 | 29 | 0 | 7 | 51 | 1 | 0 | 78 | 0 | ||
2013−14 | 367 | 27 | 30 | 12 | 436 | 636 (57.7) | 60 (50.0) | 0 | 240 | 24 | 0 | 1 | 92 | 2 | 0 | 77 | 0 | ||
2014−15 | 483 | 19 | 55 | 15 | 572 | 724 (66.7) | 65 (84.6) | 0 | 283 | 23 | 0 | 5 | 172 | 2 | 0 | 87 | 0 | ||
2015−16 |
488 |
23 |
62 |
12 |
585 |
805 (60.6) |
99 (62.6) |
0 |
238 |
34 |
2 |
8 |
197 |
2 |
0 |
104 |
0 |
||
Total |
2,587 |
163 |
247 |
76 |
3,073 |
4,673 (55.4) |
442 (55.9) |
1 |
1,820 |
141 |
4 |
30 |
571 |
10 |
1 |
494 |
1 |
||
*Laboratory-confirmed cases included culture-confirmed and PCR-confirmed cases. Data included in this study represented 55.4% of all laboratory-confirmed cases in England and 55.9% of those in Scotland. NG, nongroupable; PHE, Public Health England; PHS, Public Health Scotland. †1, England; 2, Wales; 3, Scotland; 4, Northern Ireland. ‡W/Y serogroups were combined because of inconclusive serogrouping results. |
Page created: March 19, 2018
Page updated: March 19, 2018
Page reviewed: March 19, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.